Furthermore, CP-870,893 can directly induce apoptosis in CD40-expressing tumor cells​ (184), and has been successfully combined with gemcitabine and cobimetinib in pancreatic cancer immunotherapy, helping to overcome resistance to conventional treatments​​ (186, 187). The gene discussed is CD40; the disease is neoplasm.